NEWS
-
12202501Press ReleasesTapping the Booming Pet Economy, GWOXI Stem Cell Expands into Veterinary Regenerative MedicineGwo Xi Stem Cell has established partnerships with multiple veterinary clinics, veterinary associations, and distribution partners to build a comprehensive veterinary regenerative medicine network, while continuously expanding its presence in the market.
-
16202412Press ReleasesTaiwan–Vietnam Cross-Border Collaboration Completes Phase I Clinical Trial of Stem Cell Therapy for Diabetes. Preliminary Result
Gwo Xi Stem Cell Applied Technology Co., Ltd. (TPEx: 6704) announced on December 9 that it has obtained the results of its Phase I human clinical trial for type I diabetes in collaboration with Vietnam.
-
25202411Press ReleasesGWOXI Stem Cell Capitalizes on Super-Aged Society and Taiwan’s Regenerative Medicine Act; Stem Cell Therapy Product for ChronicLooking ahead, Dr. Ming-His Chuang explained that Gwo Xi Stem Cell’s primary strategy is to prioritize domestic drug approval, while pursuing out-licensing and strategic partnerships internationally.
-
12202401EventsGWOXI Surpasses 100 PatentsThrough a solid and well-structured strategy, GWOXI Stem Cell successfully exceeded 100 patent applications in 2023. These patents cover the upstream, midstream, and downstream segments of the cell therapy industry, highlighting the depth and strength of GWOXI’s technological expertise.
-
07202507MediaGWOXI Stem Cell Company Briefing Video -
07202507MediaGWOXI Chinese Introduction Video -
07202507MediaGWOXI Brand Video 2024 -
07202507MediaGXNPC1: For the Treatment of Chronic Stroke -
07202507MediaTzu Chi DaAiVideo 2018 -
07202507MediaDiscovery Channel Taiwan: Biomedical Technology四樣台灣的生醫科技解決人類一生中可能遇到的潛在健康問題，從研發到實驗跟你說故事